• Return to Headlines

Biogen Inc Down 13.4% Since SmarTrend Downtrend Call (BIIB)

By James Quinn

SmarTrend identified a Downtrend for Biogen Inc (NASDAQ:BIIB) on February 6th, 2018 at $327.03. In approximately 1 month, Biogen Inc has returned 13.39% as of today's recent price of $283.24.

In the past 52 weeks, Biogen Inc share prices have been bracketed by a low of $223.02 and a high of $370.57 and are now at $283.24, 27% above that low price. The 200-day and 50-day moving averages have moved 0.96% lower and 0.24% higher over the past week, respectively.

Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company products address diseases such as multiple sclerosis, non-hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Biogen Inc.

Log in and add Biogen Inc (BIIB) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights biogen inc

Ticker(s): BIIB